Results 1 to 5 of 177

Foreign Investment Regulation Group Update: Spotlight on Tech M&A

Australia, European Union, France, Germany, Italy, Spain, United Kingdom, USA - November 24 2022 Our global network of Foreign Direct Investment (FDI) experts meet regularly to share key developments across our regions, to ensure our teams are…

Dr Marius Boewe, Malika Chandrasegaran, Gavin Davies, Joseph G Falcone, Alberto Frasquet, Christian Johnen, Francesca Morra, Veronica Roberts, Christopher Theris

Sanction imposed by the Spanish Competition Authority on a pharma company for misusing litigation strategies regarding patents

Spain - November 23 2022 On 21 October 2022, the Spanish National Markets and Competition Commission (CNMC) imposed a €38.9 million fine on pharmaceutical company Merck Sharp…

Pilar Carrasco, Henar González Durántez, Jose Munoz, Gonzalo Sanz-Magallón, Anna Sol

All change: Sweeping reforms loom for EU antitrust regime

European Union - November 3 2022 Our experts break down the key milestones as EU pushes through comprehensive overhaul of competition regime Ambitious, wide-ranging reforms pursued…

Lode Van Den Hende, Daniel Vowden

Digital Markets Act soon to enter into force - overview of key provisions

European Union - October 27 2022 The Digital Markets Act (DMA) is a ground-breaking piece of EU Regulation, imposing rules on platforms acting as “gatekeepers” in the digital sector…

Violetta Meli, Nika Nonveiller, Peter Rowland, Daniel Vowden

Update on the Teva Copaxone EU case. The EU Commission issues a Statement of Objections against Teva over alleged anti-competitive conduct consisting of misuse of divisional patents and a disparagement campaign against its closest competitor

European Union - October 11 2022 On 10 October 2022, the European Commission (“EU Commission“) formally adopted a Statement of Objections (“SO“) against Teva over an alleged abuse of…

Violetta Meli, Jose Munoz, Peter Rowland